Christopher W. Fulton

Array ( [id] => 1308330 [patent_doc_number] => 06617426 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-09-09 [patent_title] => 'Cysteinyl protease inhibitors' [patent_app_type] => B1 [patent_app_number] => 09/338409 [patent_app_country] => US [patent_app_date] => 1999-06-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18071 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 1058 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/617/06617426.pdf [firstpage_image] =>[orig_patent_app_number] => 09338409 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4271617 [patent_doc_number] => 06307018 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-10-23 [patent_title] => 'General chemical ligation' [patent_app_type] => 1 [patent_app_number] => 9/331507 [patent_app_country] => US [patent_app_date] => 1999-06-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 10 [patent_no_of_words] => 9682 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 241 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/307/06307018.pdf [firstpage_image] =>[orig_patent_app_number] => 331507 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1391205 [patent_doc_number] => 06548637 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-04-15 [patent_title] => 'Ligands for opioid receptors' [patent_app_type] => B1 [patent_app_number] => 09/336314 [patent_app_country] => US [patent_app_date] => 1999-06-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 40 [patent_figures_cnt] => 40 [patent_no_of_words] => 35376 [patent_no_of_claims] => 79 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 105 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/548/06548637.pdf [firstpage_image] =>[orig_patent_app_number] => 09336314 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4306598 [patent_doc_number] => 06187906 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-02-13 [patent_title] => 'Methods to improve neural outcome' [patent_app_type] => 1 [patent_app_number] => 9/332868 [patent_app_country] => US [patent_app_date] => 1999-06-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 18 [patent_no_of_words] => 10067 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 40 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/187/06187906.pdf [firstpage_image] =>[orig_patent_app_number] => 332868 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1589802 [patent_doc_number] => 06482921 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-11-19 [patent_title] => 'Uridyl peptide antibiotic (UPA) derivatives, their synthesis and use' [patent_app_type] => B1 [patent_app_number] => 09/330503 [patent_app_country] => US [patent_app_date] => 1999-06-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 26211 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/482/06482921.pdf [firstpage_image] =>[orig_patent_app_number] => 09330503 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6112599 [patent_doc_number] => 20020173468 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-11-21 [patent_title] => 'MODIFIED CYTOSTATIC AGENTS' [patent_app_type] => new [patent_app_number] => 09/269609 [patent_app_country] => US [patent_app_date] => 1999-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11787 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0173/20020173468.pdf [firstpage_image] =>[orig_patent_app_number] => 09269609 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1134777 [patent_doc_number] => 06784158 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-08-31 [patent_title] => 'Method for preparing a compound with growth hormone releasing properties' [patent_app_type] => B1 [patent_app_number] => 09/325677 [patent_app_country] => US [patent_app_date] => 1999-06-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6584 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 25 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/784/06784158.pdf [firstpage_image] =>[orig_patent_app_number] => 09325677 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4355593 [patent_doc_number] => 06291638 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-09-18 [patent_title] => 'Hepatotropic conjugates of antiviral drugs carriers thereof and pharmaceutical compositions containing them' [patent_app_type] => 1 [patent_app_number] => 9/325182 [patent_app_country] => US [patent_app_date] => 1999-06-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 19 [patent_no_of_words] => 9570 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 55 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/291/06291638.pdf [firstpage_image] =>[orig_patent_app_number] => 325182 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4277061 [patent_doc_number] => 06281194 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-08-28 [patent_title] => 'Cycloalkyl inhibitors of protein farnesyltransferase' [patent_app_type] => 1 [patent_app_number] => 9/319422 [patent_app_country] => US [patent_app_date] => 1999-06-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12514 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 68 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/281/06281194.pdf [firstpage_image] =>[orig_patent_app_number] => 319422 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1275378 [patent_doc_number] => 06649736 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-11-18 [patent_title] => 'Methods for carbon-centered radical mediated heavy hydrogen labeling of compounds' [patent_app_type] => B1 [patent_app_number] => 09/323741 [patent_app_country] => US [patent_app_date] => 1999-06-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 27 [patent_no_of_words] => 31653 [patent_no_of_claims] => 116 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/649/06649736.pdf [firstpage_image] =>[orig_patent_app_number] => 09323741 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1278553 [patent_doc_number] => 06645939 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-11-11 [patent_title] => 'Substituted -alanine derivatives as cell adhesion inhibitors' [patent_app_type] => B1 [patent_app_number] => 09/317789 [patent_app_country] => US [patent_app_date] => 1999-05-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 42617 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 268 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/645/06645939.pdf [firstpage_image] =>[orig_patent_app_number] => 09317789 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6555356 [patent_doc_number] => 20020111461 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-08-15 [patent_title] => 'LOW MOLECULAR WEIGHT PEPTIDOMIMETIC GROWTH HORMONE SECRETAGOGUES' [patent_app_type] => new [patent_app_number] => 09/316505 [patent_app_country] => US [patent_app_date] => 1999-05-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 23 [patent_figures_cnt] => 23 [patent_no_of_words] => 43684 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 8 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0111/20020111461.pdf [firstpage_image] =>[orig_patent_app_number] => 09316505 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1290614 [patent_doc_number] => 06632961 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-10-14 [patent_title] => 'Antiangiogenic drug to treat cancer, arthritis and retinopathy' [patent_app_type] => B1 [patent_app_number] => 09/316856 [patent_app_country] => US [patent_app_date] => 1999-05-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15876 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 499 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/632/06632961.pdf [firstpage_image] =>[orig_patent_app_number] => 09316856 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4328626 [patent_doc_number] => 06319902 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-11-20 [patent_title] => 'Peptide derivatives having thiazolyl-alanine residue' [patent_app_type] => 1 [patent_app_number] => 9/230821 [patent_app_country] => US [patent_app_date] => 1999-05-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 31403 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 37 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/319/06319902.pdf [firstpage_image] =>[orig_patent_app_number] => 230821 [rel_patent_id] =>[rel_patent_doc_number] =>)